IGM Biosciences (IGMS)
(Delayed Data from NSDQ)
$9.49 USD
+0.29 (3.15%)
Updated May 15, 2024 04:00 PM ET
After-Market: $9.52 +0.03 (0.32%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.52 |
EPS Last Quarter | -0.83 |
Last EPS Surprise | 1.19% |
ABR | 2.00 |
Earnings ESP
|
69.32% |
---|---|
Current Year | -2.96 |
Next Year | -3.06 |
EPS (TTM) | -4.31 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 41.54M | 0.55M | 43.15M | 24.92M |
# of Estimates | 6 | 6 | 6 | 3 |
High Estimate | 62.00M | 0.75M | 63.49M | 39.75M |
Low Estimate | 0.75M | 0.25M | 3.00M | 17.50M |
Year ago Sales | 0.45M | 0.51M | 2.13M | 43.15M |
Year over Year Growth Est. | 9,131.33% | 6.86% | 1,925.77% | -42.26% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.52 | -0.82 | -2.96 | -3.06 |
# of Estimates | 7 | 6 | 7 | 6 |
Most Recent Consensus | -0.79 | -0.82 | -3.27 | -3.07 |
High Estimate | 0.18 | -0.80 | -2.25 | -2.04 |
Low Estimate | -0.84 | -0.86 | -3.39 | -3.73 |
Year ago EPS | -1.43 | -1.04 | -4.71 | -2.96 |
Year over Year Growth Est. | 63.64% | 21.15% | 37.15% | -3.64% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 2 | 0 | 3 | 1 |
Up Last 30 Days | 2 | 0 | 3 | 1 |
Up Last 60 Days | 2 | 0 | 3 | 0 |
Down Last 7 Days | 0 | 2 | 0 | 1 |
Down Last 30 Days | 0 | 2 | 0 | 1 |
Down Last 60 Days | 0 | 2 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.52 | -0.82 | -2.96 | -3.06 |
7 Days Ago | -0.81 | -0.81 | -3.27 | -3.03 |
30 Days Ago | -0.81 | -0.81 | -3.27 | -3.03 |
60 Days Ago | -0.81 | -0.81 | -3.38 | -2.98 |
90 Days Ago | -0.90 | -0.89 | -3.85 | -3.56 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.16 | -0.83 | -2.60 | -3.47 |
Zacks Consensus Estimate | -0.52 | -0.82 | -2.96 | -3.06 |
Earnings ESP | 69.32% | -0.41% | 12.15% | -13.28% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.83 | -1.01 | -1.04 | -1.43 | NA |
Estimate | -0.84 | -1.06 | -1.25 | -1.43 | NA |
Difference | 0.01 | 0.05 | 0.21 | 0.00 | 0.07 |
Surprise | 1.19% | 4.72% | 16.80% | 0.00% | 5.68% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more